Watson acquires Uteron Pharma
Watson Pharmaceuticals Inc. has acquired Uteron Pharma SA, a Belgium-based developer of women’s health products. Watson said Wednesday that it has completed the deal, which includes an up-front cash payment of $150 million and up to $155 million in potential future milestone payments.